A recent study has shown that some gastric cancer cell lines including AGS are resistant or partially resistant to treatment of cetuximab, an inhibitory EGFR antibody for treatment of metastatic colorectal cancer, on EGF-stimulated cell migration and invasion [46]. Here, EGF is linked to gastric cancer.